NSE
AVRO INDIA LIMITEDAVROIND
AVRO INDIA LIMITED is a manufacturer of pharmaceutical products.
| Key products | Pharmaceuticals |
|---|---|
| Geography | India |
| Competitors | CIPLA, SUN PHARMA |
AI-generated overview β verify before relying on it.
Net institutional flow
+βΉ1.8 Cr
Institutional buyers
3 in / 1 out
High-impact filings
0 Β· tilt Neutral
Next corporate action
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share
ex 2026-05-05
| # | Company | Inst. flow βΉCr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +βΉ15.1 Cr | 267 | β | β | β | β |
| 2 | MOBIKWIK | +βΉ5.2 Cr | 355 | β | β | β | β |
| 3 | AVROINDThis | +βΉ0.9 Cr | 3 | β | β | β | β |
| 4 | MTNL | +βΉ0.1 Cr | 26 | β | β | β | β |
| 5 | GATECH | ββΉ0.3 Cr | 77 | β | β | β | β |
| 6 | IRMENERGY | ββΉ2.2 Cr | 356 | β | β | β | β |
| 7 | QUADFUTURE | ββΉ7.9 Cr | 177 | β | β | β | β |
Ranked by net institutional flow (buys β sells, βΉCr). Filing momentum = bullish β bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Weaknesses
- β’ Limited product diversity
- β’ Dependent on a few major customers
Opportunities
- β’ Potential for market expansion in India
- β’ Increased focus on digital marketing could improve customer reach
Threats
- β’ Economic downturn affecting consumer spending
- β’ Rising raw material costs
AI-generated from our data β verify before relying on it.
- 2026-06-17FilingAVRO INDIA LIMITED has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of keGranting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
- 2026-06-12FilingAVRO INDIA LIMITED has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-08FilingAVRO INDIA LIMITED has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-08FilingAVRO INDIA LIMITED has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on JMeeting
- 2026-05-05ActionFace Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per ShareSplit
- 2026-04-22BulkBUY Β· βΉ0.9 CrMINERVA VENTURES FUND
- 2026-04-22BulkSELL Β· βΉ0.9 CrNAUTILUS PRIVATE CAPITAL LTD
- 2026-01-14BulkBUY Β· βΉ1 CrNAUTILUS PRIVATE CAPITAL LTD
- 2026-01-14NetDay net +βΉ1 Cr
Merged from deals, filings, corporate actions and news β newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvalsNeutral
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
Source PDF β - 1
- 1
- 2
3 deals Β· 2026-01-14 β 2026-04-22
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2026-04-22 | MINERVA VENTURES FUND | Institution | BUY | βΉ0.9 Cr |
| 2026-04-22 | NAUTILUS PRIVATE CAPITAL LTD | HNI / other | SELL | βΉ0.9 Cr |
| 2026-01-14 | NAUTILUS PRIVATE CAPITAL LTD | HNI / other | BUY | βΉ1 Cr |
3 deals in the selected window β corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
News & chatter on AVROIND
RSS News
0No recent news.
Google News RSS β links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.